Welcome to LookChem.com Sign In|Join Free

CAS

  • or

65-45-2

Post Buying Request

65-45-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

65-45-2 Usage

Chemical Description

Salicylamide is a white crystalline powder that is derived from salicylic acid and used as an analgesic and antipyretic.

Description

Salicylamide, also known as o-hydroxybenzamide, is a derivative of salicylic acid that exists as odorless white or slightly pink crystals with a bitter taste. It is less acidic than other salicylic acid derivatives and is fairly stable to heat, light, and moisture. Salicylamide is an aromatic amide that is rapidly metabolized in the body and has a lower toxicity compared to other salicylates.

Uses

Used in Medicine:
Salicylamide is used as an analgesic, fungicide, and anti-inflammatory ingredient for soothing the skin. It is known for its moderately quicker and deeper analgesic effect than aspirin due to quicker central nervous system (CNS) penetration. However, it has a lower analgesic and antipyretic efficacy than aspirin because it is not metabolized to salicylic acid but rather excreted as ether glucuronide or sulfate.
Salicylamide is also used in combination with other pain-relieving substances such as aspirin and caffeine in over-the-counter pain remedies. It serves as an analgesic and antipyretic, making it a valuable component in various nonprescription products.
Used in Pharmaceutical Formulations:
Salicylamide is often combined with other active ingredients like acetaminophen and phenyltoloxamine (e.g., Rid-A Pain compound, Cetazone T, Dolorex, Ed-Flex, Lobac) or with aspirin, acetaminophen, and caffeine (e.g., Saleto, BC Powder) to enhance their therapeutic effects and provide relief from pain and fever.
Used in the Pharmaceutical Industry:
In the pharmaceutical industry, Salicylamide is utilized as a key component in the development of various medications targeting pain relief and inflammation. Its unique properties, such as rapid metabolism and lower toxicity, make it a preferred choice for formulating medications that cater to patients with sensitivity to salicylates.
Used in the Cosmetics Industry:
Due to its anti-inflammatory properties, Salicylamide is also used in the cosmetics industry as an ingredient in skincare products designed to soothe and calm the skin, particularly for those with sensitive or irritated skin conditions.

Air & Water Reactions

Salicylamide darkens on exposure to air. . Insoluble in water.

Reactivity Profile

Salicylamide is an amide. Amides/imides react with azo and diazo compounds to generate toxic gases. Flammable gases are formed by the reaction of organic amides/imides with strong reducing agents. Amides are very weak bases (weaker than water). Imides are less basic yet and in fact react with strong bases to form salts. That is, they can react as acids. Mixing amides with dehydrating agents such as P2O5 or SOCl2 generates the corresponding nitrile. The combustion of these compounds generates mixed oxides of nitrogen (NOx). Salicylamide may be sensitive to prolonged exposure to light.

Fire Hazard

Flash point data for Salicylamide are not available; however, Salicylamide is probably combustible.

Clinical Use

Whereas salicylamide is reported to be as effective as aspirin as an analgetic/antipyretic and is effective in relieving pain associated with arthritic conditions, it does not appear to possess useful anti-inflammatory activity. Thus, indications for the treatment of arthritic disease states are unwarranted, and its use is restricted to the relief of minor aches and pain at a dosage of 325 to 650 mg three or four times per day. Its effects in humans are not reliable, however, and its use is not widely recommended.

Purification Methods

Crystallise the amide from water or repeatedly from CHCl3 [Nishiya et al. J Am Chem Soc 108 3880 1986]. [Beilstein 10 IV 169.] The anilide [87-17-2] M 213.2, m 135o crystallises from H2O. [Beilstein 12 H 500, 12 I 268, 12 II 256, 12 944.]

Check Digit Verification of cas no

The CAS Registry Mumber 65-45-2 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 6 and 5 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 65-45:
(4*6)+(3*5)+(2*4)+(1*5)=52
52 % 10 = 2
So 65-45-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10)

65-45-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A10797)  Salicylamide, 98%   

  • 65-45-2

  • 250g

  • 211.0CNY

  • Detail
  • Alfa Aesar

  • (A10797)  Salicylamide, 98%   

  • 65-45-2

  • 1000g

  • 687.0CNY

  • Detail
  • Alfa Aesar

  • (A10797)  Salicylamide, 98%   

  • 65-45-2

  • 5000g

  • 2738.0CNY

  • Detail
  • Fluka

  • (84228)  Salicylamide  matrix substance for MALDI-MS, ≥99.0% (T)

  • 65-45-2

  • 84228-1G

  • 389.61CNY

  • Detail
  • USP

  • (1608000)  Salicylamide  United States Pharmacopeia (USP) Reference Standard

  • 65-45-2

  • 1608000-200MG

  • 4,662.45CNY

  • Detail

65-45-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name salicylamide

1.2 Other means of identification

Product number -
Other names Benzamide, 2-hydroxy-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65-45-2 SDS

65-45-2Synthetic route

2-ethyl-4-oxo-1,3-benzoxazinium perchlorate
56429-60-8

2-ethyl-4-oxo-1,3-benzoxazinium perchlorate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

A

2-Ethyl-1H-benzoimidazole; compound with perchloric acid
138118-62-4

2-Ethyl-1H-benzoimidazole; compound with perchloric acid

B

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
at 100℃; for 0.0833333h;A 100%
B n/a
methyl thiosalicylate
17999-25-6

methyl thiosalicylate

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With ammonia In dichloromethane at 20℃; for 6h;100%
2-(cyclohex-2-enyloxy)-benzamide

2-(cyclohex-2-enyloxy)-benzamide

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With hydrogenchloride In diethyl ether at 20℃; for 0.0166667h;98%
2-methyl-4-oxo-4H-benzo[e][1,3]oxazinium perchlorate
54789-70-7

2-methyl-4-oxo-4H-benzo[e][1,3]oxazinium perchlorate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

A

2-(methyl)benzimidazolium perchlorate
1792-35-4

2-(methyl)benzimidazolium perchlorate

B

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
at 100℃; for 0.0833333h; Product distribution; Mechanism; other 1,3-heterocyclic cations, other 1,4-binucleophiles;A 97%
B 96%
at 100℃; for 0.0833333h;A 97%
B 96%
methyl salicylate
119-36-8

methyl salicylate

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With ammonia In methanol at 50℃; for 16h; Sealed tube;94%
With sodium metabisulfite; ammonium hydroxide at 40℃; for 8h; Reagent/catalyst; Temperature;93.5%
With ammonia In aq. buffer at 45 - 50℃; under 760.051 Torr; for 1h; Reagent/catalyst; Temperature;86.2%
salicylonitrile
611-20-1

salicylonitrile

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With water at 150℃; under 5171.62 - 6205.94 Torr; for 0.5h; Inert atmosphere; Microwave irradiation;93%
With Acetaldehyde oxime; [(eta.(5)-pentamethylcyclopentadienyl)Rh(H2O)3](OTf)2 In water at 50℃; for 6h; Schlenk technique;86%
With N-ethyl-N-hydroxy-ethanamine; water; copper diacetate In ethanol at 35℃; for 3h;85%
N-(2,4-dimethoxybenzyl)-2-hydroxybenzamide

N-(2,4-dimethoxybenzyl)-2-hydroxybenzamide

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene for 2h; Heating;92%
salicylaldehyde
90-02-8

salicylaldehyde

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With hydroxylamine hydrochloride In acetonitrile for 0.0652778h; Microwave irradiation;92%
With hydroxylamine hydrochloride; methanesulfonyl chloride In neat (no solvent) at 70℃; for 3.5h;91%
With triacetonitrile 4′-(4-chlorophenyl)-2,2′:6′,2″-terpyridine ruthenium(II) nitrate; hydroxylamine hydrochloride; sodium acetate In water at 100℃; for 12h; Inert atmosphere;75%
2,2-dimethyl-4-(2-oxo-1H-pyrid-1-yl)oxy-2H-1,3-benzoxazine
74405-16-6

2,2-dimethyl-4-(2-oxo-1H-pyrid-1-yl)oxy-2H-1,3-benzoxazine

A

2-hydroxy-pyridine N-oxide
13161-30-3

2-hydroxy-pyridine N-oxide

B

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With hydrogenchloride for 3h; Product distribution; Ambient temperature;A 90%
B n/a
2-methyl-benzyl alcohol
89-95-2

2-methyl-benzyl alcohol

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With aluminum oxide; hydroxylamine hydrochloride; methanesulfonyl chloride; water at 100℃; for 1h;90%
With hydroxylamine hydrochloride; zinc(II) oxide at 140℃; for 2h; Beckmann rearrangement;80%
With hydroxylamine hydrochloride; titanium(IV) oxide at 140℃; for 3h; Beckmann rearrangement;80%
Stage #1: 2-methyl-benzyl alcohol With aluminum oxide; methanesulfonic acid at 100℃; Beckmann rearrangement;
Stage #2: With hydroxylamine hydrochloride at 140℃; for 2.5h;
80 % Spectr.
salicylaldehyde-oxime
94-67-7

salicylaldehyde-oxime

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With Cu(II) on nano silica functionalized triazine dendrimer In water at 20℃; for 0.8h; Beckmann Rearrangement; Green chemistry;90%
With toluene-4-sulfonic acid; 1,2-bis-(diphenylphosphino)ethane; carbonyl(dihydro)tris(triphenylphosphine)ruthenium(II) In 1,4-dioxane Heating;82%
With C82H80N4O6; mercury dichloride In tetrahydrofuran; water; toluene at 20℃; for 6.5h; Beckmann Rearrangement;81%
2-(aminocarbonyl)benzeneboronic acid

2-(aminocarbonyl)benzeneboronic acid

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With potassium hydroxide In dimethyl sulfoxide at 100℃; for 0.0833333h; Microwave irradiation; Green chemistry;89%
benzamide
55-21-0

benzamide

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With sodium persulfate; palladium diacetate In 1,4-dioxane at 80℃; for 16h; Inert atmosphere;88%
2-(o-hydroxyphenyl)-4-oxo-1,3-benzoxazinium perchlorate
86245-83-2

2-(o-hydroxyphenyl)-4-oxo-1,3-benzoxazinium perchlorate

naphthalene-1,8-diamine
479-27-6

naphthalene-1,8-diamine

A

2-(1H-Perimidin-2-yl)-phenol; compound with perchloric acid
138118-68-0

2-(1H-Perimidin-2-yl)-phenol; compound with perchloric acid

B

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
at 20℃; for 0.166667h;A 86%
B n/a
2-(benzyloxy)benzamide
29579-11-1

2-(benzyloxy)benzamide

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With methyl-phenyl-thioether; trifluoroacetic acid In toluene at 20℃; for 24h;83%
2-fluorobenzamide
445-28-3

2-fluorobenzamide

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With water; potassium hydroxide In dimethyl sulfoxide at 20℃; for 16h;83%
1,8-dimethylaminonaphthalene
20734-56-9

1,8-dimethylaminonaphthalene

2-ethyl-4-oxo-1,3-benzoxazinium perchlorate
56429-60-8

2-ethyl-4-oxo-1,3-benzoxazinium perchlorate

A

1,3-dimethyl-2-ethylperimidinium perchlorate

1,3-dimethyl-2-ethylperimidinium perchlorate

B

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
at 80℃; for 4h;A 77%
B 82%
salicylonitrile
611-20-1

salicylonitrile

A

salicylamide
65-45-2

salicylamide

B

salicylic acid
69-72-7

salicylic acid

Conditions
ConditionsYield
With phosphate buffer at 30℃; for 3h; rhodococcus rhodocrous AJ270, pH 7.0;A 80%
B 5%
With potassium phosphate buffer at 30℃; for 3h; Rhodococcus sp. AJ270 cells;A 80.1%
B 5%
2-styryl-1,3-benzoxazinonium perchlorate
56429-66-4

2-styryl-1,3-benzoxazinonium perchlorate

naphthalene-1,8-diamine
479-27-6

naphthalene-1,8-diamine

A

2-((E)-Styryl)-1H-perimidine; compound with perchloric acid
138118-67-9

2-((E)-Styryl)-1H-perimidine; compound with perchloric acid

B

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
at 80℃; for 0.0666667h;A 80%
B n/a
hydroxybenzaldoxime
22032-06-0

hydroxybenzaldoxime

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With aluminum oxide; methanesulfonic acid at 140℃; for 2.5h; Beckmann rearrangement;80%
With cerium(III) chloride; silica gel; sodium iodide for 0.1h; Beckmann rearrangement; microwave irradiation;79%
2-Iodophenol
533-58-4

2-Iodophenol

carbon monoxide
201230-82-2

carbon monoxide

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With 1H-imidazole; ammonium carbamate; triethylamine In N,N-dimethyl-formamide at 130℃; for 12h; Sealed tube;80%
1-cyanobenzene oxide-oxepin
73654-43-0

1-cyanobenzene oxide-oxepin

A

salicylonitrile
611-20-1

salicylonitrile

B

salicylamide
65-45-2

salicylamide

C

phenol
108-95-2

phenol

Conditions
ConditionsYield
In tetrahydrofuran; water for 48h; Heating; pH=7;A 75%
B 18%
C 7%
2-methoxybenzamide
2439-77-2

2-methoxybenzamide

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With piperazine In N,N-dimethyl acetamide at 150℃; for 8h; Substitution; Demethylation;74%
salicylic acid
69-72-7

salicylic acid

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With zirconium(IV) oxychloride; urea at 80℃; for 0.0111111h; Sealed tube; Microwave irradiation;73%
With ammonium carbonate; ortho-tungstic acid; zinc(II) oxide In 5,5-dimethyl-1,3-cyclohexadiene at 160℃; for 8h;73.7%
With pyridine; urea for 0.00555556h; microwave irradiation;70%
2-methyl-4-oxo-4H-benzo[e][1,3]oxazinium perchlorate
54789-70-7

2-methyl-4-oxo-4H-benzo[e][1,3]oxazinium perchlorate

1,2-(N,N'-dimethyl)-5-triphenylmethylphenylenediamine
138118-61-3

1,2-(N,N'-dimethyl)-5-triphenylmethylphenylenediamine

A

1,3-(N,N'-dimethyl)-2-methyl-5-triphenylmethylbenzimidazolium perchlorate

1,3-(N,N'-dimethyl)-2-methyl-5-triphenylmethylbenzimidazolium perchlorate

B

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
at 120℃; for 0.25h;A 71%
B n/a
2-methyl-4-oxo-4H-benzo[e][1,3]oxazinium perchlorate
54789-70-7

2-methyl-4-oxo-4H-benzo[e][1,3]oxazinium perchlorate

2-amino-4-methyl-N-methylaminobenzene
39513-19-4

2-amino-4-methyl-N-methylaminobenzene

A

1,2,5-trimethylbenzimidazolium perchlorate

1,2,5-trimethylbenzimidazolium perchlorate

B

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
at 100℃; for 0.0833333h;A 63%
B n/a
salicylhydroxamic acid
89-73-6

salicylhydroxamic acid

A

salicylaldehyde
90-02-8

salicylaldehyde

B

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With samarium diiodide; phosphoric acid In tetrahydrofuran; methanol for 0.000833333h; Ambient temperature;A 59%
B 40%
2-Bromobenzamide
4001-73-4

2-Bromobenzamide

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
With oxygen; triethylamine; sodium iodide In acetonitrile at 32℃; for 24h; Schlenk technique; UV-irradiation;59%
2-methyl-4-oxo-4H-benzo[e][1,3]oxazinium perchlorate
54789-70-7

2-methyl-4-oxo-4H-benzo[e][1,3]oxazinium perchlorate

naphthalene-1,8-diamine
479-27-6

naphthalene-1,8-diamine

A

2-Methyl-1H-perimidine; compound with perchloric acid
138118-66-8

2-Methyl-1H-perimidine; compound with perchloric acid

B

salicylamide
65-45-2

salicylamide

Conditions
ConditionsYield
at 80℃; for 0.0666667h;A 56%
B n/a

65-45-2Relevant articles and documents

Copper-mediated α-hydroxylation of N-salicyloyl-glycine. A model for peptidyl-glycine α-amidating monooxygenase (PAM)

Capdevielle, Patrice,Maumy, Michel

, p. 3831 - 3834 (1991)

Title compound 1 is selectively hydroxytated in α position by three distinct copper- containing oxidant systems, involving dioxygen, peroxide anion or trimethylamine oxide. Trivalent copper is likely the key intermediate in this first reported model for the PHM activity of enzyme PAM.

Efficient nitriding reagent and application thereof

-

Paragraph 0318-0320, (2021/03/31)

The invention discloses an efficient nitriding reagent and application thereof, wherein the nitriding reagent comprises nitrogen oxide, an active agent, a reducing agent and an organic solvent. By applying the nitriding reagent, nitrogen-containing compounds such as amide, nitrile and the like can be produced, and the method is simple in condition, low in waste discharge amount and simple in reaction equipment.

Preparation method of aromatic amide compound

-

Paragraph 0060-0061, (2020/07/15)

The present invention provides a preparation method of an aromatic amide compound. In an organic solvent, under the effect of a catalyst, an aromatic acid compound and an amine source are subjected toa dehydration reaction to obtain the aromatic amide compound, wherein the aromatic acid compound is an aromatic acid, a substituted aromatic acid, a heterocyclic aromatic acid or a substituted heterocyclic aromatic acid; and the substituent group of amide is any substituent group of H, a C1-C8 straight-chain alkyl or branched-chain alkyl group, a benzene ring or an aromatic ring. The aromatic amide compound is an important chemical intermediate, and the synthesis method is mild in reaction condition and high in yield.

Substrate Profiling of the Cobalt Nitrile Hydratase from Rhodococcus rhodochrous ATCC BAA 870

Mashweu, Adelaide R.,Chhiba‐Govindjee, Varsha P.,Bode, Moira L.,Brady, Dean

, (2020/01/13)

The aromatic substrate profile of the cobalt nitrile hydratase from Rhodococcus rhodochrous ATCC BAA 870 was evaluated against a wide range of nitrile containing compounds (>60). To determine the substrate limits of this enzyme, compounds ranging in size from small (90 Da) to large (325 Da) were evaluated. Larger compounds included those with a biaryl axis, prepared by the Suzuki coupling reaction, Morita–Baylis–Hillman adducts, heteroatomlinked diarylpyridines prepared by Buchwald–Hartwig crosscoupling reactions and imidazo[1,2a]pyridines prepared by the Groebke–Blackburn–Bienaymé multicomponent reaction. The enzyme active site was moderately accommodating, accepting almost all of the small aromatic nitriles, the diarylpyridines and most of the biaryl compounds and Morita–Baylis–Hillman products but not the Groebke–Blackburn–Bienaymé products. Nitrile conversion was influenced by steric hindrance around the cyano group, the presence of electron donating groups (e.g., methoxy) on the aromatic ring, and the overall size of the compound.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 65-45-2